命中率狂飆百倍!Deep Origin 結合 AI 與物理模擬,抗癌藥物發現迎突破
TechNews (TW)zh-TW

Deep Origin 近日宣布,其 AI 藥物發現框架在一項針對癌症免疫治療相關酵素的測試中,命中率接近 3 […]
This is a short summary published by AI Global Wire. The full article is owned and hosted by TechNews (TW) — open it there to read it in full.
Read the full story at TechNews (TW)Related AI news
- Huawei Cloud launches CodeArts Agent in SingaporeTech in Asia · August 29, 2026
- 不只做鞋膠!南寶挾一甲子功力華麗轉型,強攻半導體與 AI 封裝材料TechNews (TW) · August 29, 2026
- OpenAI rolls out ChatGPT ads to users in IndiaTech in Asia · August 29, 2026
- AI beyond the hypeTech in Asia · August 29, 2026
- 美光台灣工會醞釀罷工獲 8 成支持!不滿獎金分紅落後三星、SK 海力士TechNews (TW) · August 29, 2026
- Meta 前團隊新創 Perceptron 推出視覺 AI 模型 Isaac 0.5,讓機器人學會「看懂與思考」TechNews (TW) · August 28, 2026